▲ Peaking
Health
🔮 holds
CRISPR makes prostate cancer vulnerable to immunotherapy
Researchers are using CRISPR gene editing to make 'immune-cold' prostate tumors visible and vulnerable to immunotherapy.
1 news trends Newsylist has tracked involving CRISPR — newest first.
Researchers are using CRISPR gene editing to make 'immune-cold' prostate tumors visible and vulnerable to immunotherapy.